Vasorin as an actor of bone turnover?
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Caroline Andrique und 16 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Montrouge, France. Hauptthemen laut MEDLINE: Bone Remodeling, Coculture Techniques, Osteoblasts, Osteoclasts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Bone diseases are increasing with aging populations and it is important to identify clues to develop innovative treatments. Vasn , which encodes vasorin (Vasn), a transmembrane protein involved in the pathophysiology of several organs, is expressed during the development in intramembranous and endochondral ossification zones. Here, we studied the impact of Vasn deletion on the osteoblast and osteoclast dialog through a cell Coculture model. In addition, we explored the bone phenotype of Vasn KO mice, either constitutive or tamoxifen‐inducible, or with an osteoclast‐specific deletion. First, we show that both osteoblasts and osteoclasts express Vasn. Second, we report that, in both KO mouse models but not in osteoclast‐targeted KO mice, Vasn deficiency was associated with an osteopenic bone phenotype, due to an imbalance in favor of osteoclastic resorption. Finally, through the Coculture experiments, we identify a dysregulation of the Wnt/β‐catenin pathway together with an increase in RANKL release by osteoblasts, which led to an enhanced osteoclast activity. This study unravels a direct role of Vasn in bone turnover, introducing a new biomarker or potential therapeutic target for bone pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris Cité, Montrouge, France.
- AP-HP, Services de médecine bucco-dentaire: GH Nord - Université Paris Cité, GH Sorbonne Université, GH Henri Mondor, Paris, France.
- Paris Cardiovascular Research Centre - PARCC, Université Paris Cité, Inserm, Paris, France.
- Department of Developmental Genetics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
- Université Paris Cité, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.
- URP 7517 UPJV, Pathophysiological Mechanisms and Consequences of Cardiovascular Calcifications (MP3CV), Jules Verne University of Picardie, Amiens, France.
ORCID-Profile: Caroline Andrique, Anne Laure Bonnet, Julien Dang, Julie Lesieur, Jeremy Sadoine, Gael Y Rochefort, Claire Bardet, Isabelle Six, Pierre Louis Tharaux, Celine Gaucher, Catherine Chaussain
Förderung
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
Zitieren
APA
Andrique, C., Bonnet, A. L., Dang, J., Lesieur, J., Krautzberger, A. M., Baroukh, B., Torrens, C., Sadoine, J., Schmitt, A., Rochefort, G. Y., Bardet, C., Six, I., Houillier, P., Tharaux, P. L., Schrewe, H., Gaucher, C., & Chaussain, C. (2024). Vasorin as an actor of bone turnover?. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31257
Vancouver
Andrique C, Bonnet AL, Dang J, Lesieur J, Krautzberger AM, Baroukh B, et al. Vasorin as an actor of bone turnover?. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31257
BibTeX
@article{Andrique2024,
author = {Andrique, Caroline and Bonnet, Anne Laure and Dang, Julien and Lesieur, Julie and Krautzberger, A Michaela and Baroukh, Brigitte and Torrens, Coralie and Sadoine, Jeremy and Schmitt, Alain and Rochefort, Gael Y and Bardet, Claire and Six, Isabelle and Houillier, Pascal and Tharaux, Pierre Louis and Schrewe, Heinrich and Gaucher, Celine and Chaussain, Catherine},
title = {Vasorin as an actor of bone turnover?},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31257}
}
EUVIMED